ST Pharm Co.Ltd (237690) — Financial Flexibility Index
ST Pharm Co.Ltd (237690) has a Financial Flexibility Index of -0.08x as of December 2025. Free cash flow of ₩-15.27 Billion (operating CF ₩-21.16 Billion minus capex ₩5.89 Billion) represents 0% of total liabilities (₩189.56 Billion). Check 237690 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ST Pharm Co.Ltd Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for ST Pharm Co.Ltd across 11 annual periods. For the full cash flow conversion analysis, see 237690 cash flow conversion.
Annual Financial Flexibility Index for ST Pharm Co.Ltd (2015–2025)
Year-by-year free cash flow to debt coverage for ST Pharm Co.Ltd. Explore ST Pharm Co.Ltd (237690) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | ₩61.27 Billion | ₩13.99 Billion | ₩189.56 Billion | ▼ -63.3% |
| 2024 | 0.88x | ₩192.68 Billion | ₩109.45 Billion | ₩218.88 Billion | ▲ +467.7% |
| 2023 | 0.16x | ₩44.74 Billion | ₩1.30 Billion | ₩288.53 Billion | ▼ -46.6% |
| 2022 | 0.29x | ₩67.69 Billion | ₩7.03 Billion | ₩233.02 Billion | ▼ -13.6% |
| 2021 | 0.34x | ₩59.06 Billion | ₩7.27 Billion | ₩175.59 Billion | ▲ +1380.8% |
| 2020 | -0.03x | ₩-3.95 Billion | ₩-20.93 Billion | ₩150.24 Billion | ▲ +95.7% |
| 2019 | -0.61x | ₩-24.30 Billion | ₩-30.52 Billion | ₩40.12 Billion | ▼ -122.2% |
| 2018 | 2.72x | ₩37.93 Billion | ₩10.77 Billion | ₩13.94 Billion | ▲ +0.8% |
| 2017 | 2.70x | ₩82.13 Billion | ₩54.44 Billion | ₩30.42 Billion | ▲ +120.4% |
| 2016 | 1.23x | ₩66.81 Billion | ₩50.78 Billion | ₩54.53 Billion | ▲ +121.0% |
| 2015 | 0.55x | ₩58.22 Billion | ₩35.82 Billion | ₩105.04 Billion | — |